Medical device company GI Dynamics (ASX:GID) shares are in pre-open following the ASX granting the company a trading halt.
GID requested the halt pending a material announcement regarding its business.
The company is developing innovative treatments for type 2 diabetes and obesity.
Revenue increased to US$2.8 million for the year ended 31 December 2014 compared to US$2.3 million for the year ended 31 December 2013.
The halt will remain in place until the opening of trade on Monday 9th March 2015, or earlier if an announcement is made to the market.
